CD300b regulates intestinal inflammation and promotes repair in colitis.
Ontology highlight
ABSTRACT: Chronic inflammation is a hallmark charataristic of various inflammatory diseases including inflammatory bowel disease. Subsequently, current therapeutic approaches target immune-mediated pathways as means for therapeutic intervention and promotion of mucosal healing and repair. Emerging data demonstrate important roles for CD300 receptor family members in settings of innate immunity as well as in allergic and autoimmune diseases. One of the main pathways mediating the activities of CD300 family members is via promotion of resolution through interactions with ligands expressed by viruses, bacteria, or dead cells (e.g., phospholipids such as PtdSer and/or ceramide). We have recently shown that the expression of CD300a, CD300b and CD300f were elevated in patients with IBD and that CD3
SUBMITTER: Avlas S
PROVIDER: S-EPMC10073762 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA